is a compounded tirzepatide safe methylcobalamin compound versions of (Mounjaro, Zepbound) containing vitamin B12 pose potential safety risk Compounded Tirzepatide Explained: Key Facts

The dose is a tool you adjust based on two signals: your results and your tolerance

The second coprimary endpoint was percentage achieving at least a 5% reduction in body weight at 72 weeks between the semaglutide 7.2 mg group and the placebo group

This is not usually a problem for Threshold Substances (at least not now see below for historical injustices relating to Threshold Substances), as an adjustment is made, as set out in Technical Document TD2019DL, in order to avoid the risk of false positives arising from an athletes hydration status

However, some individuals may benefit from higher doses depending on their health goals and conditions